Navigation Links
Blood Pressure Checks To Be Done For Children As Young As Age 3

The government has set new standards for measuring blood pressure in children based on age, weight, height and sex. According to the latest standards // children as young as age 3 should receive regular blood pressure checks.

Kids who fall in the 95th percentile for blood pressure are diagnosed with high blood pressure. Kids who fall between the 90th percentile and 95th percentiles are said to have pre-hypertension -- a relatively new classification aimed at treating borderline high blood pressure before it becomes a full-fledged problem. Adolescents are diagnosed like adults -- problems start when blood pressure reaches 120/80 millimeters of mercury.

In all cases, the guidelines recommend lifestyle modifications, such as losing weight, improving diet, and increasing physical activity, to get blood pressure back to normal. In serious cases, drug therapy is warranted. Some children may also need to be tested for an enlargement of the main pumping chamber of the heart, a key sign high blood pressure is doing damage to the body.

Researchers say the long-term health risks for hypertensive children and adolescents can be substantial, hence it is very important that clinical measures be taken to reduce risks and to optimize positive health outcomes.
'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
(Date:7/25/2008)...s second quarter financial results -, LAVAL, QC, ...SX: DDS;,NASDAQ: DDSS) today announced that it wil...30 a.m. (ET) to discuss its second quarter 2008,fi...quarter 2008 financial,results via news release at... the conference call by telephone, dial 416-646-30...
(Date:7/25/2008)...oducts reduces lung function, increases asthma ris...(HealthDay News) -- A clean, fresh-smelling home m...hat type of cleaning and air freshening products y...e to cleaning products or air fresheners that cont...ed 1,4 dicholorobenzene (1,4 DCB), can reduce lung...
(Date:7/25/2008)...swire/ -- BeaconEquity.com announces the,availabil... Investors can view all of the daily trading notes..., Today,s Trade Alerts include: DUSA Pharmaceutic...cals Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,...nc. (Nasdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABA...
(Date:7/25/2008)... of Marketing Exclusivity Begins -, CORONA, Calif...ceuticals, Inc. (NYSE: WPI ), a leading specialty...subsidiary has commenced commercial,shipment of it...in the 40mg,strength from its Davie, Florida manuf... Watson has 180 days of marketing exclusivity for ...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
...eport published online today in the Annals of Onco...rmone treatments such as tamoxifen would prefer to...ons //were thought o significantly curb the occurr...urveyed nearly 200 breast cancer patients and aske...
...arterial calcifications (BACs) are common findings...media layer of the peripheral arterioles and this ...clerosis or medial arterial calcification. Many gr... diabetes and cardiovascular risk, but there are f...
...of researchers at Fox Chase Cancer Center in Phila...of prostate cancer may not turn up to seek fresh t...ted on the behalf of the Radiation Therapy Oncolog...rican Society for Therapeutic Radiation and Oncolo...
...US one of the top organ transplant hospitals in Ca... allegations a Saudi national improperly received ...atients.// The Los Angeles Times reported that of...also discovered that, following the transplant, so...
Other Medicine News:Health News:Association Of Breast Arterial Calcifications With Diabetes And Hypertension 2
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Medic...g solutions for more than 20 years, has entered,th...hnology to measure,regional oxygen saturation. Tod...s the continuous monitoring of the regional blood ...arly testing data and outcomes from an ongoing cli...
(Date:7/22/2008)... Study Demonstrates Feasibility and Efficacy of Tr...ary Liver Cancer, SAN FRANCISCO, and YONGIN-SI, S... (San Francisco, CA and Ottawa, Ontario), and its ...today that novel findings from,a Phase I clinical ...monstrated that the product was well-tolerated and...
(Date:7/22/2008)... CEO Geoffrey Allan Will Stress the Importance to ...iologics Approval Pathway, RICHMOND, Va., July 22... INSM) a developer of follow-on biologics and biop...n, Ph.D., CEO of Insmed, will present at a,Congres...uss the,significant need for establishing an appro...
(Date:7/22/2008)...st Developed and Validated by Columbia University ..., Proprietary MicroRNA Technology, The Test Diff...ll Lung Cancer (NSCLC), Classifying Squamous-Cell...96 Percent and Specificity of 90 Percent,This is t...NAs, Sensitivity as Biomarkers for Accura...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 1David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 2David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 3David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 4Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 1Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 2Millennium Ships and Records the First 24200 000 of Revenue Generated From the Five Year 2420 000 000 Exclusive Purchase Order 2095 3PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 1PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 2PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 3PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 4PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 5PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 6PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 7PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 8PROCRIT 28R 29 28Epoetin Alfa 29 Data to be Presented at American Society of Hematology Annual Meeting 997 9Diabetes Linked to Blood Vessel Inflammation 7756 1Diabetes Linked to Blood Vessel Inflammation 7756 2
...lia--(BUSINESS WIRE)--Jul 5, 2007 - Australian,bio... the,completion of apricitabine,s controlled, doub...k segment of its Phase IIb trial.,Patients have no...ial (weeks 24 to 48) and will continue to receive ...ily treatment regime.,The Company expects to relea...
...xas--(BUSINESS WIRE)--Jul 5, 2007 - Repros,Therape... article,has been published in the July 1, 2007 is... a new approach to the treatment of,breast cancer ...rom,a study conducted in an accepted in vivo rat m...collaboration with scientists,from the University ...
Other Medicine Technology:Avexa's Apricitabine Clinical Trial Update 2Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 2Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 3Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer 4
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: